Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential
L Gao, Y Zhang, K Sterling, W Song - Translational neurodegeneration, 2022 - Springer
Synaptic abnormalities are a cardinal feature of Alzheimer's disease (AD) that are known to
arise as the disease progresses. A growing body of evidence suggests that pathological …
arise as the disease progresses. A growing body of evidence suggests that pathological …
BDNF therapeutic mechanisms in neuropsychiatric disorders
AH Bazzari, FH Bazzari - International Journal of Molecular Sciences, 2022 - mdpi.com
Brain-derived neurotrophic factor (BDNF) is the most abundant neurotrophin in the adult
brain and functions as both a primary neurotrophic signal and a neuromodulator. It serves …
brain and functions as both a primary neurotrophic signal and a neuromodulator. It serves …
Dendrimer as a momentous tool in tissue engineering and regenerative medicine
A Shaikh, P Kesharwani, V Gajbhiye - Journal of Controlled Release, 2022 - Elsevier
Dendrimers have been comprehensively used for cargo delivery, nucleic acid delivery
(genes, miRNA/siRNAs), delivery of macromolecules, and other various biomedical …
(genes, miRNA/siRNAs), delivery of macromolecules, and other various biomedical …
Neurodegenerative disease and brain delivery of therapeutics: Bridging the gap using dendrimers
Neurodegenerative diseases (NDs) continue to burden human lives and economic
conditions. They continue to challenge the healthcare system due to the associated …
conditions. They continue to challenge the healthcare system due to the associated …
Targeted Bioluminescent Imaging of Pancreatic Ductal Adenocarcinoma Using Nanocarrier-Complexed EGFR-Binding Affibody–Gaussia Luciferase Fusion Protein
In vivo imaging has enabled impressive advances in biological research, both preclinical
and clinical, and researchers have an arsenal of imaging methods available …
and clinical, and researchers have an arsenal of imaging methods available …
Recent advances in multifunctional dendrimer‐based complexes for cancer treatment
D Shcharbin, V Zhogla, V Abashkin… - Wiley …, 2024 - Wiley Online Library
The application of nanotechnology in biological and medical fields have resulted in the
creation of new devices, supramolecular systems, structures, complexes, and composites …
creation of new devices, supramolecular systems, structures, complexes, and composites …
Self-assembled nanoscale materials for neuronal regeneration: a focus on BDNF protein and nucleic acid biotherapeutic delivery
Y Wu, M Rakotoarisoa, B Angelov, Y Deng, A Angelova - Nanomaterials, 2022 - mdpi.com
Enabling challenging applications of nanomedicine and precision medicine in the treatment
of neurodegenerative disorders requires deeper investigations of nanocarrier-mediated …
of neurodegenerative disorders requires deeper investigations of nanocarrier-mediated …
The impact of serum protein adsorption on PEGylated NT3–BDNF nanoparticles—distribution, protein release, and cytotoxicity in a human retinal pigmented epithelial …
M Dąbkowska, A Kosiorowska, B Machaliński - Pharmaceutics, 2023 - mdpi.com
The adsorption of biomolecules on nanoparticles' surface ultimately depends on the
intermolecular forces, which dictate the mutual interaction transforming their physical …
intermolecular forces, which dictate the mutual interaction transforming their physical …
[HTML][HTML] Nanoparticles as a therapeutic delivery system for skin cancer prevention and treatment
J Chang, B Yu, WM Saltzman, M Girardi - JID Innovations, 2023 - Elsevier
The use of nanoparticles (NPs) as a therapeutic delivery system has expanded markedly
over the past decade, particularly regarding applications targeting the skin. The delivery of …
over the past decade, particularly regarding applications targeting the skin. The delivery of …
Photoenhanced cytosolic protein delivery based on a photocleavable group-modified dendrimer
Numerous recently developed therapies have highlighted the advantages of using proteins
as therapeutics. However, in many protein delivery systems, the complicated carrier designs …
as therapeutics. However, in many protein delivery systems, the complicated carrier designs …